Increasing gap junctional coupling: A tool for dissecting the role of gap junctions

Journal of Membrane Biology

Volumn 216, Issue 1, 2007, Pages 23-35

  Axelsen, Lene Nygaard ^a   Haugan, Ketil ^b   Stahlhut, Martin ^a   Kjølbye, Anne Louise ^a   Hennan, James K ^c   Holstein Rathlou, Niels Henrik ^d   Petersen, Jørgen Søberg ^a   Nielsen, Morten Schak ^d  

^a Zealand Pharma AS   (Denmark)

^b BISPEBJERG HOSPITAL   (Denmark)

^c PFIZER INC   (United States)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Arrhythmia Infarct size; Connexin Antiarrhythmic peptide; Gap junction; Osteopenia Connexin gating RXP E

Indexed keywords

ANTIARRHYTHMIC PEPTIDE; ANTIARRHYTHMIC PEPTIDE 10; GAP JUNCTION PROTEIN; ROTIGAPTIDE; UNCLASSIFIED DRUG; AAP 10; ANTIARRHYTHMIC AGENT; CONNEXIN 43; OLIGOPEPTIDE;

ARRHYTHMOGENESIS; CELL JUNCTION; CHANNEL GATING; DRUG MECHANISM; GAP JUNCTION; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE ARRHYTHMIA; HOMEOSTASIS; NONHUMAN; OSTEOBLAST; OVARIECTOMY; PROTEIN BINDING; REVIEW; ANIMAL; BONE; CELL COMMUNICATION; DRUG EFFECT; FEMALE; HUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIA; ATRIAL FIBRILLATION; BONE AND BONES; CELL COMMUNICATION; CONNEXIN 43; FEMALE; GAP JUNCTIONS; HOMEOSTASIS; HUMANS; ION CHANNEL GATING; MYOCARDIAL ISCHEMIA; OLIGOPEPTIDES; OSTEOBLASTS;

EID: 35448942707     PISSN: 00222631     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00232-007-9026-z     Document Type: Review

References (110)

1. Ai Z, Fischer A, Spray DC, Brown AM, Fishman GI (2000) Wnt-1 regulation of connexin43 in cardiac myocytes. J Clin Invest 105:161-171
2. Anyukhovsky EP, Sosunov EA, Plotnikov A, Gainullin RZ, Jhang JS, Marboe CC, Rosen MR (2002) Cellular electrophysiologic properties of old canine atria provide a substrate for arrhythmogenesis. Cardiovasc Res 54:462-469
3. Aonuma S, Kohama Y, Akai K, Komiyama Y, Nakajima S, Wakabayashi M, Makino T (1980) Studies on heart. XIX. Isolation of an atrial peptide that improves the rhythmicity of cultured myocardial cell clusters. Chem Pharm Bull (Tokyo) 28:3332-3339
4. Aonuma S, Kohama Y, Makino T, Fujisawa Y (1982) Studies of heart. XXI. Amino acid sequence of antiarrhythmic peptide (AAP) isolated from atria. J Pharmacobiodyn 5:40-48
5. Argentieri T, Cantor E, Wiggins JR (1989) Antiarrhythmic peptide has no direct cardiac actions. Experientia 45:737-738
6. Axelsen LN, Stahlhut M, Mohammed S, Larsen BD, Nielsen MS, Holstein-Rathlou NH, Andersen S, Jensen ON, Hennan JK, Kjolbye AL (2006) Identification of ischemia-regulated phosphorylation sites in connexin43: a possible target for the antiarrhythmic peptide analogue rotigaptide (ZP123). J Mol Cell Cardiol 40:790-798
7. Azarnia R, Loewenstein WR (1984) Intercellular communication and the control of growth: XI. Alteration of junctional permeability by the src gene in a revertant cell with normal cytoskeleton. J Membr Biol 82:207-212
8. Beardslee MA, Lerner DL, Tadros PN, Laing JG, Beyer EC, Yamada KA, Kleber AG, Schuessler RB, Saffitz JE (2000) Dephosphorylation and intracellular redistribution of ventricular connexin43 during electrical uncoupling induced by ischemia. Circ Res 87:656-662
9. Bernus O, Zemlin CW, Zaritsky RM, Mironov SF, Pertsov AM (2005) Alternating conduction in the ischaemic border zone as precursor of reentrant arrhythmias: a simulation study. Europace 7(Suppl 2):93-104
10. 2+ homeostasis and cell death. J Neurochem 70:958-970
11. 2-sensitive and voltage-sensitive. Biophys J 72:2137-2142
12. Cabo C, Boyden PA (2006) Heterogeneous gap junction remodeling stabilizes reentrant circuits in the epicardial border zone of the healing canine infarct: a computational study. Am J Physiol 291:H2606-H2616
13. Calero G, Kanemitsu M, Taffet SM, Lau AF, Delmar M (1998) A 17mer peptide interferes with acidification-induced uncoupling of connexin43. Circ Res 82:929-935
14. Cherian PP, Cheng B, Gu S, Sprague E, Bonewald LF, Jiang JX (2003) Effects of mechanical strain on the function of gap junctions in osteocytes are mediated through the prostaglandin EP2 receptor. J Biol Chem 278:43146-43156
15. Chung DJ, Castro CH, Watkins M, Stains JP, Chung MY, Szejnfeld VL, Willecke K, Theis M, Civitelli R (2006) Low peak bone mass and attenuated anabolic response to parathyroid hormone in mice with an osteoblast-specific deletion of connexin43. J Cell Sci 119:4187-4198
16. Civitelli R, Beyer EC, Warlow PM, Robertson AJ, Geist ST, Steinberg TH (1993) Connexin43 mediates direct intercellular communication in human osteoblastic cell networks. J Clin Invest 91:1888-1896
17. 2) and parathyroid hormone (PTH) in osteoblastic cells. J Cell Biochem 68:8-21
18. Clarke TC, Thomas D, Petersen JS, Evans WH, Martin PE (2006) The antiarrhythmic peptide rotigaptide (ZP123) increases gap junction intercellular communication in cardiac myocytes and HeLa cells expressing connexin 43. Br J Pharmacol 147:486-495
19. Dhein S, Hammerath SB (2001) Aspects of the intercellular communication in aged hearts: effects of the gap junction uncoupler palmitoleic acid. Naunyn Schmiedebergs Arch Pharmacol 364:397-408
20. Dhein S, Larsen BD, Petersen JS, Mohr FW (2003) Effects of the new antiarrhythmic peptide ZP123 on epicardial activation and repolarization pattern. Cell Commun Adhes 10:371-378
21. Dhein S, Manicone N, Müller A, Gerwin R, Ziskoven U, Irankhani A, Minke C, Klaus W (1994) A new synthetic antiarrhythmic peptide reduces dispersion of epicardial activation recovery interval and diminishes alterations of epicardial activation patterns induced by regional ischemia. A mapping study. Naunyn Schmiedebergs Arch Pharmacol 350:174-184
22. Dikshit M, Srivastava R, Kundu B, Mathur KB, Kar K (1988) Antiarrhythmic and antithrombotic effect of antiarrhythmic peptide and its synthetic analogues. Indian J Exp Biol 26:874-876
23. Dorian P, Zhong J, So PSS, Debicki D, Hennan JK (2005) Increasing gap junction conductance with ZP123 improves defibrillation success in experimental cardiac arrest [abstract]. Circulation 112:II-115
24. Duffy HS, Delmar M, Spray DC (2002a) Formation of the gap junction nexus: binding partners for connexins. J Physiol Paris 96:243-249
25. Duffy HS, Sorgen PL, Girvin ME, O'Donnell P, Coombs W, Taffet SM, Delmar M, Spray DC (2002b) pH-dependent intramolecular binding and structure involving Cx43 cytoplasmic domains. J Biol Chem 277:36706-36714
26. Ek-Vitorin JF, Calero G, Morley GE, Coombs W, Taffet SM, Delmar M (1996) pH regulation of connexin43: molecular analysis of the gating particle. Biophys J 71:1273-1284
27. Eloff BC, Gilat E, Wan X, Rosenbaum DS (2003) Pharmacological modulation of cardiac gap junctions to enhance cardiac conduction: evidence supporting a novel target for antiarrhythmic therapy. Circulation 108:3157-3163
28. Eloff BC, Lerner DL, Yamada KA, Schuessler RB, Saffitz JE, Rosenbaum DS (2001) High resolution optical mapping reveals conduction slowing in connexin43 deficient mice. Cardiovasc Res 51:681-690
29. Evans WH, Boitano S (2001) Connexin mimetic peptides: specific inhibitors of gap-junctional intercellular communication. Biochem Soc Trans 29:606-612
30. Garcia-Dorado D, Inserte J, Ruiz-Meana M, Gonzalez MA, Solares J, Julia M, Barrabes JA, Soler-Soler J (1997) Gap junction uncoupler heptanol prevents cell-to-cell progression of hypercontracture and limits necrosis during myocardial reperfusion. Circulation 96:3579-3586
31. Garcia-Dorado D, Rodriguez-Sinovas A, Ruiz-Meana M (2004) Gap junction-mediated spread of cell injury and death during myocardial ischemia-reperfusion. Cardiovasc Res 61:386-401
32. Garcia-Dorado D, Theroux P, Duran JM, Solares J, Alonso J, Sanz E, Munoz R, Elizaga J, Botas J, Fernandez-Aviles F (1992) Selective inhibition of the contractile apparatus. A new approach to modification of infarct size, infarct composition, and infarct geometry during coronary artery occlusion and reperfusion. Circulation 85:1160-1174
33. Gluhak-Heinrich J, Gu S, Pavlin D, Jiang JX (2006) Mechanical loading stimulates expression of connexin 43 in alveolar bone cells in the tooth movement model. Cell Commun Adhes 13:115-125
34. Guerra JM, Everett TH, Lee KW, Wilson E, Olgin JE (2006) Effects of the gap junction modifier rotigaptide (ZP123) on atrial conduction and vulnerability to atrial fibrillation. Circulation 114:110-118
35. Guerrero PA, Schuessler RB, Davis LM, Beyer EC, Johnson CM, Yamada KA, Saffitz JE (1997) Slow ventricular conduction in mice heterozygous for a connexin43 null mutation. J Clin Invest 99:1991-1998
36. Gutstein DE, Morley GE, Tamaddon H, Vaidya D, Schneider MD, Chen J, Chien KR, Stuhlmann H, Fishman GI (2001) Conduction slowing and sudden arrhythmic death in mice with cardiac-restricted inactivation of connexin43. Circ Res 88:333-339
37. Gysembergh A, Kloner RA, Przyklenk K (2001) Pretreatment with the gap junction uncoupler heptanol does not limit infarct size in rabbit heart. Cardiovasc Pathol 10:13-17
38. Hagendorff A, Schumacher B, Kirchhoff S, Luderitz B, Willecke K (1999) Conduction disturbances and increased atrial vulnerability in connexin40-deficient mice analyzed by transesophageal stimulation. Circulation 99:1508-1515
39. Haugan K, Lam HR, Knudsen CB, Petersen JS (2004) Atrial fibrillation in rats induced by rapid transesophageal atrial pacing during brief episodes of asphyxia: a new in vivo model. J Cardiovasc Pharmacol 44:125-135
40. Haugan K, Marcussen N, Kjolbye AL, Nielsen MS, Hennan JK, Petersen JS (2006a) Treatment with the gap junction modifier rotigaptide (ZP123) reduces infarct size in rats with chronic myocardial infarction. J Cardiovasc Pharmacol 47:236-242
41. Haugan K, Miyamoto T, Takeishi Y, Kubota I, Nakayama J, Shimojo H, Hirose M (2006b) Rotigaptide (ZP123) improves atrial conduction slowing in chronic volume overload-induced dilated atria. Basic Clin Pharmacol Toxicol 99:71-79
42. Haugan K, Olsen KB, Hartvig L, Petersen JS, Holstein-Rathlou NH, Hennan JK, Nielsen MS (2005) The antiarrhythmic peptide analog ZP123 prevents atrial conduction slowing during metabolic stress. J Cardiovasc Electrophysiol 16:537-545
43. Hayashi H, Wang C, Miyauchi Y, Omichi C, Pak HN, Zhou S, Ohara T, Mandel WJ, Lin SF, Fishbein MC, Chen PS, Karagueuzian HS (2002) Aging-related increase to inducible atrial fibrillation in the rat model. J Cardiovasc Electrophysiol 13:801-808
44. Hennan JK, Swillo RE, Morgan GA, Keith JC Jr, Schaub RG, Smith RP, Feldman HS, Haugan K, Kantrowitz J, Wang PJ, bu-Qare A, Butera J, Larsen BD, Crandall DL (2006) Rotigaptide (ZP123) prevents spontaneous ventricular arrhythmias and reduces infarct size during myocardial ischemia/reperfusion injury in open-chest dogs. J Pharmacol Exp Ther 317:236-243
45. Huelsing DJ, Spitzer KW, Pollard AE (2000) Electrotonic suppression of early afterdepolarizations in isolated rabbit Purkinje myocytes. Am J Physiol 279:H250-H259
46. Ilvesaro J, Vaananen K, Tuukkanen J (2000) Bone-resorbing osteoclasts contain gap-junctional connexin-43. J Bone Miner Res 15:919-926
47. Iovine MK, Higgins EP, Hindes A, Coblitz B, Johnson SL (2005) Mutations in connexin43 (GJA1) perturb bone growth in zebrafish fins. Dev Biol 278:208-219
48. Jain SK, Schuessler RB, Saffitz JE (2003) Mechanisms of delayed electrical uncoupling induced by ischemic preconditioning. Circ Res 92:1138-1144
49. Jones SJ, Gray C, Sakamaki H, Arora M, Boyde A, Gourdie R, Green C (1993) The incidence and size of gap junctions between the bone cells in rat calvaria. Anat Embryol (Berl) 187:343-352
50. Jørgensen NR, Teilmann SC, Henriksen Z, Meier E, Hansen SS, Jensen JE, Sørensen OH, Petersen JS (2005) The antiarrhythmic peptide analog rotigaptide (ZP123) stimulates gap junction intercellular communication in human osteoblasts and prevents decrease in femoral trabecular bone strength in ovariectomized rats. Endocrinology 146:4745-4754
51. Kagiyama Y, Hill JL, Gettes LS (1982) Interaction of acidosis and increased extracellular potassium on action potential characteristics and conduction in guinea pig ventricular muscle. Circ Res 51:614-623
52. Kanno S, Kovacs A, Yamada KA, Saffitz JE (2003) Connexin43 as a determinant of myocardial infarct size following coronary occlusion in mice. J Am Coll Cardiol 41:681-686
53. Kanno Y, Loewenstein WR (1964) Low-resistance coupling between gland cells. Some observations on intercellular contact membranes and intercellular space. Nature 201:194-195
54. Keevil VL, Huang CL, Chau PL, Sayeed RA, Vandenberg JI (2000) The effect of heptanol on the electrical and contractile function of the isolated, perfused rabbit heart. Pfluegers Arch 440:275-282
55. King TJ, Bertram JS (2005) Connexins as targets for cancer chemoprevention and chemotherapy. Biochim Biophys Acta 1719:146-160
56. Kirchhoff S, Kim JS, Hagendorff A, Thonnissen E, Kruger O, Lamers WH, Willecke K (2000) Abnormal cardiac conduction and morphogenesis in connexin40 and connexin43 double-deficient mice. Circ Res 87:399-405
57. Kitamura H, Ohnishi Y, Yoshida A, Okajima K, Azumi H, Ishida A, Galeano EJ, Kubo S, Hayashi Y, Itoh H, Yokoyama M (2002) Heterogeneous loss of connexin43 protein in nonischemic dilated cardiomyopathy with ventricular tachycardia. J Cardiovasc Electrophysiol 13:865-870
58. 2 (ZP123): in vivo and in vitro studies. J Pharmacol Exp Ther 306:1191-1199
59. Kohama Y, Kuwahara S, Yamamoto K, Okabe M, Mimura T, Fukaya C, Watanabe M, Yokoyama K (1988) Effect of N-3-(4-hydroxyphenyl)propionyl Pro-Pro-Gly-Ala-Gly on calcium-induced arrhythmias. Chem Pharm Bull (Tokyo) 36:4597-4599
60. Kohama Y, Okimoto N, Mimura T, Fukaya C, Watanabe M, Yokoyama K (1987) A new antiarrhythmic peptide, N-3-(4-hydroxyphenyl)propionyl Pro-Hyp- Gly-Ala-Gly. Chem Pharm Bull (Tokyo) 35:3928-3930
61. Kostin S, Klein G, Szalay Z, Hein S, Bauer EP, Schaper J (2002) Structural correlate of atrial fibrillation in human patients. Cardiovasc Res 54:361-379
62. Laird DW (2006) Life cycle of connexins in health and disease. Biochem J 394:527-543
63. Lampe PD, Lau AF (2004) The effects of connexin phosphorylation on gap junctional communication. Int J Biochem Cell Biol 36:1171-1186
64. Lecanda F, Warlow PM, Sheikh S, Furlan F, Steinberg TH, Civitelli R (2000) Connexin43 deficiency causes delayed ossification, craniofacial abnormalities, and osteoblast dysfunction. J Cell Biol 151:931-944
65. Lerner DL, Yamada KA, Schuessler RB, Saffitz JE (2000) Accelerated onset and increased incidence of ventricular arrhythmias induced by ischemia in Cx43-deficient mice. Circulation 101:547-552
66. Li D, Fareh S, Leung TK, Nattel S (1999) Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort. Circulation 100:87-95
67. Li G, Whittaker P, Yao M, Kloner RA, Przyklenk K (2002) The gap junction uncoupler heptanol abrogates infarct size reduction with preconditioning in mouse hearts. Cardiovasc Pathol 11:158-165
68. Loewenstein WR, Kanno Y (1966) Intercellular communication and the control of tissue growth: lack of communication between cancer cells. Nature 209:1248-1249
69. Matchkov VV, Rahman A, Peng H, Nilsson H, Aalkjaer C (2004) Junctional and nonjunctional effects of heptanol and glycyrrhetinic acid derivates in rat mesenteric small arteries. Br J Pharmacol 142:961-972
70. Moreno AP, Chanson M, Elenes S, Anumonwo J, Scerri I, Gu H, Taffet SM, Delmar M (2002) Role of the carboxyl terminal of connexin43 in transjunctional fast voltage gating. Circ Res 90:450-457
71. Moreno AP, Rook MB, Fishman GI, Spray DC (1994a) Gap junction channels: distinct voltage-sensitive and -insensitive conductance states. Biophys J 67:113-119
72. Moreno AP, Saez JC, Fishman GI, Spray DC (1994b) Human connexin43 gap junction channels. Regulation of unitary conductances by phosphorylation. Circ Res 74:1050-1057
73. Müller A, Gottwald M, Tudyka T, Linke W, Klaus W, Dhein S (1997a) Increase in gap junction conductance by an antiarrhythmic peptide. Eur J Pharmacol 327:65-72
74. Müller A, Schaefer T, Linke W, Tudyka T, Gottwald M, Klaus W, Dhein S (1997b) Actions of the antiarrhythmic peptide AAP10 on intercellular coupling. Naunyn Schmiedebergs Arch Pharmacol 356:76-82
75. Nao T, Ohkusa T, Hisamatsu Y, Inoue N, Matsumoto T, Yamada J, Shimizu A, Yoshiga Y, Yamagata T, Kobayashi S, Yano M, Hamano K, Matsuzaki M (2003) Comparison of expression of connexin in right atrial myocardium in patients with chronic atrial fibrillation versus those in sinus rhythm. Am J Cardiol 91:678-683
76. Nattel S (2004) The clinical relevance of connexin gating: how to control communication in the heart. Heart Rythm 1:234
77. Nelson WL, Makielski JC (1991) Block of sodium current by heptanol in voltage-clamped canine cardiac Purkinje cells. Circ Res 68:977-983
78. Ohara T, Qu Z, Lee MH, Ohara K, Omichi C, Mandel WJ, Chen PS, Karagueuzian HS (2002) Increased vulnerability to inducible atrial fibrillation caused by partial cellular uncoupling with heptanol. Am J Physiol 283:H1116-H1122
79. Paznekas WA, Boyadjiev SA, Shapiro RE, Daniels O, Wollnik B, Keegan CE, Innis JW, Dinulos MB, Christian C, Hannibal MC, Jabs EW (2003) Connexin 43 (GJA1) mutations cause the pleiotropic phenotype of oculodentodigital dysplasia. Am J Hum Genet 72:408-418
80. Peters NS, Coromilas J, Severs NJ, Wit AL (1997) Disturbed connexin43 gap junction distribution correlates with the location of reentrant circuits in the epicardial border zone of healing canine infarcts that cause ventricular tachycardia. Circulation 95:988-996
81. Qi X, Varma P, Newman D, Dorian P (2001) Gap junction blockers decrease defibrillation thresholds without changes in ventricular refractoriness in isolated rabbit hearts. Circulation 104:1544-1549
82. Quan W, Rudy Y (1990) Unidirectional block and reentry of cardiac excitation: a model study. Circ Res 66:367-382
83. Ren Y, Zhang CT, Wu J, Ruan YF, Pu J, He L, Wu W, Chen BD, Wang WG, Wang L (2006) The effects of antiarrhythmic peptide AAP10 on ventricular arrhythmias in rabbits with healed myocardial infarction. Zhonghua Xin Xue Guan Bing Za Zhi 34:825-828
84. Robinson JA, Chatterjee-Kishore M, Yaworsky PJ, Cullen DM, Zhao W, Li C, Kharode Y, Sauter L, Babij P, Brown EL, Hill AA, Akhter MP, Johnson ML, Recker RR, Komm BS, Bex FJ (2006) Wnt/beta-catenin signaling is a normal physiological response to mechanical loading in bone. J Biol Chem 281:31720-31728
85. Rohr S, Kucera JP, Kleber AG (1998) Slow conduction in cardiac tissue. I: Effects of a reduction of excitability versus a reduction of electrical coupling on microconduction. Circ Res 83:781-794
86. Ronsberg MA, Saunders TK, Chan PS, Cervoni P (1986) The antiarrhythmic effect of antiarrhythmic peptide (Gly-Pro-4Hyp-Gly-Ala-Gly) and its analog on chemically-induced arrhythmias in mice. Med Sci 14:350-351
87. Saltman AE, Aksehirli TO, Valiunas V, Gaudette GR, Matsuyama N, Brink P, Krukenkamp IB (2002) Gap junction uncoupling protects the heart against ischemia. J Thorac Cardiovasc Surg 124:371-376
88. Schiller PC, Mehta PP, Roos BA, Howard GA (1992) Hormonal regulation of intercellular communication: parathyroid hormone increases connexin 43 gene expression and gap-junctional communication in osteoblastic cells. Mol Endocrinol 6:1433-1440
89. Schirrmacher K, Schmitz I, Winterhager E, Traub O, Brummer F, Jones D, Bingmann D (1992) Characterization of gap junctions between osteoblast-like cells in culture. Calcif Tissue Int 51:285-290
90. Schlack W, Preckel B, Barthel H, Obal D, Thamer V (1997) Halothane reduces reperfusion injury after regional ischaemia in the rabbit heart in vivo. Br J Anaesth 79:88-96
91. Schlack W, Uebing A, Schafer M, Bier F, Schafer S, Piper HM, Thamer V (1994) Regional contractile blockade at the onset of reperfusion reduces infarct size in the dog heart. Pfluegers Arch 428:134-141
92. Schwanke U, Konietzka I, Duschin A, Li X, Schulz R, Heusch G (2002) No ischemic preconditioning in heterozygous connexin43-deficient mice. Am J Physiol 283:H1740-H1742
93. Sebbag L, Verbinski SG, Reimer KA, Jennings RB (2003) Protection of ischemic myocardium in dogs using intracoronary 2,3-butanedione monoxime (BDM). J Mol Cell Cardiol 35:165-176
94. Seki A, Duffy HS, Coombs W, Spray DC, Taffet SM, Delmar M (2004) Modifications in the biophysical properties of connexin43 channels by a peptide of the cytoplasmic loop region. Circ Res 95:e22-e28
95. Shibayama J, Lewandowski R, Kieken F, Coombs W, Shah S, Sorgen PL, Taffet SM, Delmar M (2006) Identification of a novel peptide that interferes with the chemical regulation of connexin43. Circ Res 98:1365-1372
96. Shiroshita-Takeshita A, Sakabe M, Haugan K, Hennan JK, Nattel S (2007) Model-dependent effects of the gap junction conduction-enhancing antiarrhythmic peptide rotigaptide (ZP123) on experimental atrial fibrillation in dogs. Circulation 115:310-318
97. Sims JJ, Schoff KL, Loeb JM, Wiegert NA (2003) Regional gap junction inhibition increases defibrillation thresholds. Am J Physiol 285:H10-H16
98. Stahlhut M, Petersen JS, Hennan JK, Ramirez MT (2006) The antiarrhythmic peptide rotigaptide (ZP123) increases connexin 43 protein expression in neonatal rat ventricular cardiomyocytes. Cell Commun Adhes 13:21-27
99. van der Heyden MA, Rook MB, Hermans MM, Rijksen G, Boonstra J, Defize LH, Destree OH (1998) Identification of connexin43 as a functional target for Wnt signalling. J Cell Sci 111(Pt 12):1741-1749
100. Verheule S, van Batenburg CA, Coenjaerts FE, Kirchhoff S, Willecke K, Jongsma HJ (1999) Cardiac conduction abnormalities in mice lacking the gap junction protein connexin40. J Cardiovasc Electrophysiol 10:1380-1389
101. Weingart R, Bukauskas FF (1993) Gap junction channels of insects exhibit a residual conductance. Pfluegers Arch 424:192-194
102. Weng S, Lauven M, Schaefer T, Polontchouk L, Grover R, Dhein S (2002) Pharmacological modification of gap junction coupling by an antiarrhythmic peptide via protein kinase C activation. FASEB J 16:1114-1116
103. Wetzel U, Boldt A, Lauschke J, Weigl J, Schirdewahn P, Dorszewski A, Doll N, Hindricks G, Dhein S, Kottkamp H (2005) Expression of connexins 40 and 43 in human left atrium in atrial fibrillation of different aetiologies. Heart 91:166-170
104. Wilders R, Wagner MB, Golod DA, Kumar R, Wang YG, Goolsby WN, Joyner RW, Jongsma HJ (2000) Effects of anisotropy on the development of cardiac arrhythmias associated with focal activity. Pfluegers Arch 441:301-312
105. Willecke K, Eiberger J, Degen J, Eckardt D, Romualdi A, Guldenagel M, Deutsch U, Sohl G (2002) Structural and functional diversity of connexin genes in the mouse and human genome. Biol Chem 383:725-737
106. Xing D, Kjølbye AL, Nielsen MS, Petersen JS, Harlow KW, Holstein-Rathlou NH, Martins JB (2003) ZP123 increases gap junctional conductance and prevents reentrant ventricular tachycardia during myocardial ischemia in open chest dogs. J Cardiovasc Electrophysiol 14:510-520
107. Xing D, Kjolbye AL, Petersen JS, Martins JB (2005) Pharmacological stimulation of cardiac gap junction coupling does not affect ischemia-induced focal ventricular tachycardia or triggered activity in dogs. Am J Physiol 288:H511-H516
108. Yasui K, Kada K, Hojo M, Lee JK, Kamiya K, Toyama J, Opthof T, Kodama I (2000) Cell-to-cell interaction prevents cell death in cultured neonatal rat ventricular myocytes. Cardiovasc Res 48:68-76
109. Yellowley CE, Li Z, Zhou Z, Jacobs CR, Donahue HJ (2000) Functional gap junctions between osteocytic and osteoblastic cells. J Bone Miner Res 15:209-217
110. Zhao L, Naber N, Cooke R (1995) Muscle cross-bridges bound to actin are disordered in the presence of 2,3-butanedione monoxime. Biophys J 68:1980-1990